InvestorsHub Logo
Followers 122
Posts 6384
Boards Moderated 0
Alias Born 08/17/2014

Re: biotechrulz post# 150

Friday, 06/17/2016 11:23:15 AM

Friday, June 17, 2016 11:23:15 AM

Post# of 1386
Don't forget to add "breakthrough status". I believe the Phase I results presented at ASCO may qualify the company to receive breakthrough status to the current savage treatments that are out there. The FDA is allowing the company to use prior 1980 data to push to a phase II/III. And so this new dosing is at the very least good enough to land the Company a Fast Track approval. But as for the stock, I suspect another $5.40 test is coming first. Short lived the first time now that folks are finding out about this stock.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent KTRA News